Teachers Advisors LLC grew its position in CVS Health Corporation (NYSE:CVS) by 16.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,697,065 shares of the pharmacy operator’s stock after buying an additional 235,809 shares during the quarter. Teachers Advisors LLC owned approximately 0.17% of CVS Health worth $136,546,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the business. Gemmer Asset Management LLC lifted its position in shares of CVS Health by 15.3% in the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after purchasing an additional 200 shares in the last quarter. TB Alternative Assets Ltd. purchased a new stake in shares of CVS Health in the second quarter worth approximately $121,000. SRS Capital Advisors Inc. lifted its position in shares of CVS Health by 48.2% in the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after purchasing an additional 734 shares in the last quarter. Grace & White Inc. NY purchased a new stake in shares of CVS Health in the second quarter worth approximately $199,000. Finally, Nadler Financial Group Inc. purchased a new stake in shares of CVS Health in the second quarter worth approximately $202,000. Institutional investors own 81.42% of the company’s stock.

In other CVS Health news, EVP Thomas M. Moriarty sold 90,267 shares of the stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the transaction, the executive vice president now owns 70,102 shares in the company, valued at $5,580,820.22. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO David M. Denton sold 237,078 shares of the stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $79.65, for a total value of $18,883,262.70. Following the transaction, the chief financial officer now owns 141,096 shares in the company, valued at approximately $11,238,296.40. The disclosure for this sale can be found here. In the last quarter, insiders have sold 714,125 shares of company stock worth $58,119,381. Corporate insiders own 0.61% of the company’s stock.

CVS Health Corporation (NYSE CVS) opened at $70.55 on Friday. The firm has a market cap of $71,466.59, a P/E ratio of 12.36, a P/E/G ratio of 1.21 and a beta of 0.86. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67. CVS Health Corporation has a 52-week low of $66.45 and a 52-week high of $84.72.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating the consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The company had revenue of $46.18 billion for the quarter, compared to the consensus estimate of $46.17 billion. During the same quarter last year, the company posted $1.64 earnings per share. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. equities analysts expect that CVS Health Corporation will post 5.9 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.83%. CVS Health’s dividend payout ratio (DPR) is presently 41.32%.

A number of analysts have recently issued reports on the stock. Royal Bank Of Canada assumed coverage on shares of CVS Health in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price target for the company. Jefferies Group LLC increased their price target on shares of CVS Health from $82.00 to $86.00 and gave the stock a “hold” rating in a research report on Friday, September 15th. BidaskClub raised shares of CVS Health from a “sell” rating to a “hold” rating in a research report on Wednesday, August 2nd. Needham & Company LLC reaffirmed a “hold” rating on shares of CVS Health in a research report on Sunday, September 10th. Finally, Wolfe Research lowered shares of CVS Health from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $89.00 to $82.00 in a research report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $85.82.

TRADEMARK VIOLATION WARNING: “CVS Health Corporation (CVS) Holdings Lifted by Teachers Advisors LLC” was published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.watchlistnews.com/cvs-health-corporation-cvs-holdings-lifted-by-teachers-advisors-llc/1727194.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.